Your browser doesn't support javascript.
loading
The Effect of Aminocaproic Acid and Prednisolone in the Traumatic Hyphema
Journal of the Korean Ophthalmological Society ; : 697-702, 1995.
Artigo em Coreano | WPRIM | ID: wpr-98526
ABSTRACT
It is recognized that rebleeding of traumatic hyphema may predispose patients to several complications including decreased visual acuity. We reviewed the medical records of 92 patients(92 eyes) with the diagnosis of nonperforating traumatic hyphema. The relative efficiencies of Aminocaproic acid and systemic Predisolone for reducing rate of rebleeding and their side effects were evaluated under the statistical analysis. Fourty-seven patients received an oral dosage of 50 mg/kg of Aminocaproic acid every 4 hours for 5 days(up to a maximum 30 gm/day), and fourty-five patients took an oral dosage of 0.6 mg/kg of Prednisolone daily in two devided doses. The frequency of rebleeding was not statistically significantly different between the aminocaproic acid treated group(4.3%, 2/47 patients) and the prednisolone treated group(6.7%, 3/45 patients). The developing rates of their acute adverse reaction were statistically different between the aminocaproic acid treated group(44.7%, 21/47 patients) and the prednisolone treated group(20%, 9/45 patients).
Assuntos

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Hifema / Prednisolona / Acuidade Visual / Prontuários Médicos / Diagnóstico / Ácido Aminocaproico Tipo de estudo: Estudo diagnóstico Limite: Humanos Idioma: Coreano Revista: Journal of the Korean Ophthalmological Society Ano de publicação: 1995 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Hifema / Prednisolona / Acuidade Visual / Prontuários Médicos / Diagnóstico / Ácido Aminocaproico Tipo de estudo: Estudo diagnóstico Limite: Humanos Idioma: Coreano Revista: Journal of the Korean Ophthalmological Society Ano de publicação: 1995 Tipo de documento: Artigo